North America Vascular Stents Market Report by Product Type (Coronary Stents, Peripheral Vascular Stents, EVAR Stent Grafts), Material (Metallic Stents, and Others), Mode of Delivery (Balloon-Expandable Stents, Self-Expanding Stents), End-User (Hospitals and Cardiac Centers, Ambulatory Surgical Centers), and Country 2024-2032
The North America vascular stents market size reached US$ 3.7 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 5.8 Billion by 2032, exhibiting a growth rate (CAGR) of 4.9% during 2024-2032.
Vascular stents are rigid devices used for providing support to hollow, usually tubular, structures held at a position to prevent arterial blockages. They are usually made up of non-absorbable materials, such as stainless steel or cobalt–chromium alloys, polyethylene and polypropylene. The stents help patients to restore blood flow through arteries during angioplasty. They also help in maintaining the patency of stenotic vessels and avoid re-blockage caused by blood accumulation or excessive tissue growth.
The North America vascular stents market is currently being driven by several factors. The increasing obesity levels, rising smoking and alcohol consumption, and hypertension often lead to various cardiovascular diseases, such as coronary heart and peripheral vascular disorders which require vascular stenting as a treatment. Moreover, there is an escalating demand for advanced devices to cater to the healthcare needs of the increasing geriatric population in the region, thereby driving the vascular stents market. Apart from this, various types of vascular stents, including coronary stents, peripheral vascular stents and EVAR stent grafts, are currently available in the healthcare sector to serve the rising demand. Additionally, rapid technological advancements coupled with the increasing healthcare expenditures in the region have spurred the demand for vascular stents. Furthermore, other benefits, such as short recovery time, low risk of infection, minimized bleeding and lower cost of vascular stents as compared to conventional surgical methods, are expected to fuel the market growth in the region.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the North America vascular stents market report, along with forecasts at the regional and country level from 2024-2032. Our report has categorized the market based on product type, material, mode of delivery and end-user.
Key Regions Analysed
United States
Canada
Mexico
Analysis for Each Country
Market by Product Type
Coronary Stents
Peripheral Vascular Stents
EVAR Stent Grafts
Market by Material
Metallic Stents
Cobalt Chromium
Platinum Chromium
Nickel Titanium
Stainless Steel
Others
Market by Mode of Delivery
Balloon-Expandable Stents
Self-Expanding Stents
Market by End-User
Hospitals and Cardiac Centers
Ambulatory Surgical Centers
Value Chain Analysis
Key Drivers and Challenges
Porters Five Forces Analysis
PESTEL Analysis
Government Regulations
Competitive Landscape
Competitive Structure
Key Player Profiles
Key Questions Answered in This Report:
How has the North America vascular stents market performed so far and how will it perform in the coming years?
What are the key regions in the North America vascular stents market?
What has been the impact of COVID-19 on the North America vascular stents market?
What is the breakup of the North America vascular stents market on the basis of product type?
What is the breakup of the North America vascular stents market on the basis of material?
What is the breakup of the North America vascular stents market on the basis of mode of delivery?
What is the breakup of the North America vascular stents market on the basis of end-user?
What are the various stages in the value chain of the North America vascular stents industry?
What are the key driving factors and challenges in the North America vascular stents industry?
What is the structure of the North America vascular stents industry and who are the key players?
What is the degree of competition in the North America vascular stents industry?